HK1047042A1 - Conjugates and methods for the production thereof,and their use for transporting molecules via biol ogical membranes - Google Patents

Conjugates and methods for the production thereof,and their use for transporting molecules via biol ogical membranes

Info

Publication number
HK1047042A1
HK1047042A1 HK02108623A HK02108623A HK1047042A1 HK 1047042 A1 HK1047042 A1 HK 1047042A1 HK 02108623 A HK02108623 A HK 02108623A HK 02108623 A HK02108623 A HK 02108623A HK 1047042 A1 HK1047042 A1 HK 1047042A1
Authority
HK
Hong Kong
Prior art keywords
conjugates
membranes
production
methods
molecules via
Prior art date
Application number
HK02108623A
Other languages
English (en)
Inventor
Eugen Uhlmann
Beate Greiner
Eberhard Unger
Gislinde Gothe
Marc Schwerdel
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1047042A1 publication Critical patent/HK1047042A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • AIDS & HIV (AREA)
HK02108623A 1999-07-28 2002-11-29 Conjugates and methods for the production thereof,and their use for transporting molecules via biol ogical membranes HK1047042A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19935302A DE19935302A1 (de) 1999-07-28 1999-07-28 Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen
PCT/EP2000/006936 WO2001008707A2 (de) 1999-07-28 2000-07-20 Konjugate und verfahren zu deren herstellung sowie deren verwendung zum transport von molekülen über biologische membranen

Publications (1)

Publication Number Publication Date
HK1047042A1 true HK1047042A1 (en) 2003-02-07

Family

ID=7916258

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108623A HK1047042A1 (en) 1999-07-28 2002-11-29 Conjugates and methods for the production thereof,and their use for transporting molecules via biol ogical membranes

Country Status (33)

Country Link
US (1) US8420396B2 (xx)
EP (1) EP1204430B1 (xx)
JP (1) JP4791665B2 (xx)
KR (1) KR100721696B1 (xx)
CN (1) CN1227035C (xx)
AR (1) AR029385A1 (xx)
AT (1) ATE447413T1 (xx)
AU (1) AU776114B2 (xx)
BR (1) BR0012757A (xx)
CA (1) CA2377977C (xx)
CY (1) CY1109744T1 (xx)
CZ (1) CZ2002300A3 (xx)
DE (2) DE19935302A1 (xx)
DK (1) DK1204430T3 (xx)
EE (1) EE05303B1 (xx)
ES (1) ES2335741T3 (xx)
HK (1) HK1047042A1 (xx)
HR (1) HRP20020074B1 (xx)
HU (1) HUP0201995A3 (xx)
IL (2) IL147527A0 (xx)
ME (1) MEP56408A (xx)
MX (1) MXPA01013114A (xx)
NO (1) NO334155B1 (xx)
NZ (1) NZ516838A (xx)
PL (1) PL202881B1 (xx)
PT (1) PT1204430E (xx)
RS (2) RS20100249A (xx)
RU (1) RU2275936C2 (xx)
SI (1) SI1204430T1 (xx)
SK (1) SK287654B6 (xx)
TR (4) TR201109491T2 (xx)
WO (1) WO2001008707A2 (xx)
ZA (1) ZA200200657B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129251A1 (en) * 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
US7026166B2 (en) * 2002-01-22 2006-04-11 Chiron Corporation Fluorogenic dyes
US7704756B2 (en) 2003-01-21 2010-04-27 Novartis Vaccines And Diagnostics, Inc. Fluorogenic dyes
US20070167388A1 (en) * 2003-09-11 2007-07-19 Universitätsklinikum Schleswig-Holstein Campus Lübeck Nucleotide sequences promoting the trans-membrane transport of nucleic acids
JP4989225B2 (ja) * 2003-09-25 2012-08-01 コーリー ファーマシューティカル グループ，インコーポレイテッド 核酸親油性接合体
EP1886681A3 (en) * 2004-10-07 2008-11-19 Sulfidris S.r.l. 5-(p-hydroxyphenyl)-3H-1,2-dithiol-3-thione valproate ester
KR100690199B1 (ko) * 2006-04-20 2007-03-12 이화여자대학교 산학협력단 구리 이온 선택성을 갖는 플루오레세인 유도체, 이의제조방법 및 이를 이용한 생체 내 구리 이온 검출방법
RU2010112771A (ru) * 2007-10-09 2011-11-20 Коули Фармасьютикал ГмбХ (DE) Иммуностимулирующие аналоги олигонуклеотидов, содержащие модифицированные сахарные группировки
ES2605990T3 (es) 2010-12-29 2017-03-17 F. Hoffmann-La Roche Ag Conjugados de molécula pequeña para la administración intracelular de ácidos nucleicos
SG11201608880VA (en) 2014-05-23 2016-11-29 Genzyme Corp Multiple oligonucleotide moieties on peptide carrier
US20180036312A1 (en) * 2016-08-02 2018-02-08 ISI Life Sciences Inc. Novel Scaffolds for Intracellular Compound Delivery for the Detection of Cancer Cells
EP3493855A4 (en) 2016-08-02 2020-04-01 ISI Life Sciences, Inc. METHOD FOR DETECTION OF CANCER CELLS.
US10753942B2 (en) 2017-05-15 2020-08-25 Indicator Systems International, Inc. Methods to detect remnant cancer cells
US10539567B2 (en) * 2017-05-15 2020-01-21 Indicator Systems International, Inc. Biopsy methods and devices
KR20230096856A (ko) 2021-12-22 2023-06-30 한국과학기술연구원 신규 펩타이드-올리고뉴클레오티드 접합체 및 이의 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801070D0 (sv) 1988-03-23 1988-03-23 Pharmacia Ab Method for immobilizing a dna sequence on a solid support
WO1995006659A1 (en) * 1992-07-01 1995-03-09 Isis Pharmaceuticals, Inc. Amine-derivatized nucleosides and oligonucleosides
US6228982B1 (en) 1992-05-22 2001-05-08 Benget Norden Double-stranded peptide nucleic acids
US6335434B1 (en) 1998-06-16 2002-01-01 Isis Pharmaceuticals, Inc., Nucleosidic and non-nucleosidic folate conjugates
US6033909A (en) 1992-01-22 2000-03-07 Hoechst Aktiengesellschaft Oligonucleotide analogs, their preparation and use
IL104461A (en) 1992-01-22 2001-05-20 Hoechst Ag Analogs of oligonucleotide, their preparation and pharmaceutical preparations containing them
US5633360A (en) * 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
US5820873A (en) 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
DE19502912A1 (de) 1995-01-31 1996-08-01 Hoechst Ag G-Cap Stabilisierte Oligonucleotide
US5698411A (en) 1995-05-18 1997-12-16 Coulter Corporation Method for determining activity of enzymes in metabolically active whole cells
WO1998020887A1 (en) * 1996-11-14 1998-05-22 Brigham And Women's Hospital, Inc. Polyphosphoinositide binding peptides for intracellular drug delivery
GB9809084D0 (en) 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
DE19824535A1 (de) * 1998-06-03 1999-12-09 Roche Diagnostics Gmbh Neue Rhodamin-Derivate und deren Verwendung
US6335432B1 (en) 1998-08-07 2002-01-01 Bio-Red Laboratories, Inc. Structural analogs of amine bases and nucleosides
US6080580A (en) 1998-10-05 2000-06-27 Isis Pharmaceuticals Inc. Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
AU5376500A (en) 1999-06-17 2001-01-09 Universiteit Gent Functional poly-alpha-aminoacid derivatives useful for the modification of biologically active materials and their application

Also Published As

Publication number Publication date
IL147527A (en) 2006-08-01
IL147527A0 (en) 2002-08-14
DE50015781D1 (de) 2009-12-17
BR0012757A (pt) 2002-04-02
MXPA01013114A (es) 2002-06-04
TR201109493T2 (tr) 2012-03-21
PL202881B1 (pl) 2009-07-31
JP2003505517A (ja) 2003-02-12
SK1172002A3 (en) 2002-08-06
ES2335741T3 (es) 2010-04-05
DK1204430T3 (da) 2010-03-29
ZA200200657B (en) 2003-09-23
WO2001008707A3 (de) 2001-11-08
AU776114B2 (en) 2004-08-26
SK287654B6 (sk) 2011-05-06
CA2377977A1 (en) 2001-02-08
TR200706709T2 (tr) 2008-02-21
RS51447B (sr) 2011-04-30
HRP20020074B1 (en) 2011-01-31
EP1204430A2 (de) 2002-05-15
NO334155B1 (no) 2013-12-23
YU90301A (sh) 2004-05-12
CZ2002300A3 (cs) 2002-05-15
HUP0201995A3 (en) 2005-02-28
RU2275936C2 (ru) 2006-05-10
CN1227035C (zh) 2005-11-16
EP1204430B1 (de) 2009-11-04
KR20020031392A (ko) 2002-05-01
AR029385A1 (es) 2003-06-25
JP4791665B2 (ja) 2011-10-12
WO2001008707A2 (de) 2001-02-08
NO20020367D0 (no) 2002-01-23
CN1360507A (zh) 2002-07-24
US20080071069A1 (en) 2008-03-20
SI1204430T1 (sl) 2010-03-31
HRP20020074A2 (en) 2005-10-31
CA2377977C (en) 2011-09-20
TR200200222T2 (tr) 2002-07-22
ATE447413T1 (de) 2009-11-15
TR201109491T2 (tr) 2012-02-21
RS20100249A (xx) 2011-02-28
NZ516838A (en) 2004-07-30
PT1204430E (pt) 2010-01-26
HUP0201995A2 (en) 2002-10-28
KR100721696B1 (ko) 2007-05-28
MEP56408A (en) 2011-05-10
PL353069A1 (en) 2003-10-06
US8420396B2 (en) 2013-04-16
NO20020367L (no) 2002-03-26
EE05303B1 (et) 2010-06-15
EE200200035A (et) 2003-04-15
DE19935302A1 (de) 2001-02-08
CY1109744T1 (el) 2014-09-10
AU6825200A (en) 2001-02-19

Similar Documents

Publication Publication Date Title
ZA200201494B (en) Benzodiazepin derivatives, the production and use thereof.
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
NO20024281D0 (no) Indolderivater, fremgangsmåte for fremstilling av de samme og anvendelse derav
HK1047042A1 (en) Conjugates and methods for the production thereof,and their use for transporting molecules via biol ogical membranes
AU4903101A (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
AU1368300A (en) Cold-active beta galactosidase, the process for its preparation and the use thereof
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU2011501A (en) Benzimidazoles, production thereof and the use thereof as antithrombotic
HK1034916A1 (en) Body weight supports and teaching aid.
IL145041A (en) Morpholine derivatives, methods for the production thereof and pharmaceutical preparations
HU0001397D0 (en) 3-amino-3-arylpropan-1-ol derivatives, production and use thereof
HUP0201559A2 (en) Process for preparing benzimidazole derivatives and their intermediates, and the novel intermediates
HK1061655A1 (en) Caloporoside derivatives, methods for the production thereof and their use
AU4321202A (en) Sterile, stable milk and method for the production thereof
HK1036519A1 (en) Voltage-nonlinear resistance and process for producing the same.
AU4781000A (en) 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof
AU1141901A (en) Cell constructs that are suitable for immunotherapy, the production and the use thereof
PL350056A1 (en) Elastic insert, method for the production and use thereof
ZA200003586B (en) Therapeutic article.
DK1107793T3 (da) Dextran-leptin-konjugater, farmaceutiske præparater og relaterede fremgangsmåder
SI1372670T1 (en) Caloporoside derivatives, methods for the production thereof and their use
NO20004714L (no) Fyllstoffinneholdende bindemiddelblanding, fremgangsmÕte for fremstilling av blandingen, og anvendelse derav

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140720